La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Riluzole »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Rifampin < Riluzole < Risk  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000091 (2000) T. Boraud [France] ; E. Bezard ; J M Stutzmann ; B. Bioulac ; C E GrossEffects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
000094 (2000) A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. MoussaouiThe protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000217 (2001) O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. FégerRiluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000223 (2002) Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta ImperatoNeuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000256 (2002) Aïcha Douhou [France] ; Thomas Debeir ; Mario Gustavo Murer ; Louis Do ; Noëlle Dufour ; Véronique Blanchard ; Saliha Moussaoui ; Georg Andrees Bohme ; Yves Agid [France] ; Rita Raisman-VozariEffect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice.
000934 (2008) Gilbert Bensimon [France] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; Marie Vidailhet [France] ; Christine Payan [France] ; P. Nigel Leigh [Royaume-Uni]Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
001C73 (1994) A. Boireau [France] ; P. Dubédat ; F. Bordier ; C. Peny ; J M Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
001C89 (1994) A. Boireau [France] ; J M Miquet ; P. Dubédat ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism: partial antagonism of MPP(+)-induced increase in striatal extracellular dopamine in rats in vivo.
001E04 (1995) A. Benazzouz [France] ; T. Boraud ; P. Dubédat ; A. Boireau ; J M Stutzmann ; C. GrossRiluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
001E34 (1996) P. Barnéoud [France] ; M. Mazadier ; J M Miquet ; S. Parmentier ; P. Dubédat ; A. Doble ; A. BoireauNeuroprotective effects of riluzole on a model of Parkinson's disease in the rat.
001E74 (1997) S. Palfi [France] ; D. Riche ; E. Brouillet ; M C Guyot ; V. Mary ; F. Wahl ; M. Peschanski ; J M Stutzmann ; P. HantrayeRiluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.
001F43 (1998) E. Bezard [France] ; J M Stutzmann ; C. Imbert ; T. Boraud ; A. Boireau ; C E GrossRiluzole delayed appearance of parkinsonian motor abnormalities in a chronic MPTP monkey model.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Riluzole" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Riluzole" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Riluzole
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024